Get the app
US › Healthcare

Mustang Bio Inc (MBIO)

US · Healthcare · Biotechnology

$0.38-2.59%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-1.1M
EPS
$-0.16

Key statistics

Market cap
$2.9M
Forward P/E
0.0
P/B
0.51
Book value
$1.00
EPS (TTM)
$-0.44
52-week high
$1.69
52-week low
$0.37
50-day MA
$0.51
200-day MA
$0.72
Beta
2.09

Analyst view

with an average price target of $10.00.

Shareholding

Insiders
8.02%
Institutions
9.93%

Largest institutional holders

FundStake
Kestra Advisory Services, LLC2.60%
BlackRock Inc1.12%
Citadel Advisors Llc0.78%
Geode Capital Management, LLC0.56%
CFO4Life Group, LLC0.44%
Vanguard Fiduciary Trust Co0.42%
Vanguard Capital Management, LLC0.34%
XTX Topco Ltd0.19%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Mustang Bio Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.